T. Rowe Price Investment Management, Inc.
Position in TECH — BIO-TECHNE Corp
CIK 1897612
BALTIMORE, MD
Position in TECH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$60,116,716
+$58,168,576 QoQ
Shares Held
1,150,339
+3372.6% QoQ
Ownership
0.734%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $12,305,680,119 across 52 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
6,754,846 | $1,801,652,525 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,642,173 | $1,698,463,338 | |
| 3 | CYTK |
Cytokinetics Inc
|
18,718,498 | $1,594,628,844 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
6,257,261 | $717,520,118 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
12,207,450 | $709,619,068 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
30,912,287 | $686,561,894 | |
| 7 | CGON |
CG Oncology, Inc.
|
6,616,899 | $470,130,673 | |
| 8 | IMNM |
Immunome Inc.
|
19,676,883 | $416,953,150 |
All Filings in TECH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,116,716 | 1,150,339 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,948,140 | 33,126 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $65,189,848 | 1,171,847 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $63,699,987 | 1,238,095 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $34,236,496 | 428,331 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $28,153,219 | 392,927 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,982,498 | 141,817 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||